The DINO trial - challenges for translation into clinical practice

C Collins; Robert Gibson; Maria Makrides

doi:10.1002/lite.201100139

The DINO trial - challenges for translation into clinical practice

C Collins, Robert Gibson, Maria Makrides

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

Infants born prematurely require higher amounts of dietary docosahexaenoic acid (DHA) than can be supplied through current strategies. Increasing the DHA content of breast milk and formula while achievable may not be the most efficacious approach. A new approach is required that enables direct delivery to the infant enabling maximum dose to be achieved as early as possible.

Original language	English
Pages (from-to)	200-202
Number of pages	3
Journal	Lipid Technology
Volume	23
Issue number	9
DOIs	https://doi.org/10.1002/lite.201100139
Publication status	Published - Sep 2011

Access to Document

10.1002/lite.201100139

Cite this

@article{30675acaff3746daabee1a02beec56a5,

title = "The DINO trial - challenges for translation into clinical practice",

abstract = "Infants born prematurely require higher amounts of dietary docosahexaenoic acid (DHA) than can be supplied through current strategies. Increasing the DHA content of breast milk and formula while achievable may not be the most efficacious approach. A new approach is required that enables direct delivery to the infant enabling maximum dose to be achieved as early as possible.",

author = "C Collins and Robert Gibson and Maria Makrides",

year = "2011",

month = sep,

doi = "10.1002/lite.201100139",

language = "English",

volume = "23",

pages = "200--202",

journal = "Lipid Technology",

issn = "0956-666X",

publisher = "Wiley-VCH Verlag",

number = "9",

}

TY - JOUR

T1 - The DINO trial - challenges for translation into clinical practice

AU - Collins, C

AU - Gibson, Robert

AU - Makrides, Maria

PY - 2011/9

Y1 - 2011/9

N2 - Infants born prematurely require higher amounts of dietary docosahexaenoic acid (DHA) than can be supplied through current strategies. Increasing the DHA content of breast milk and formula while achievable may not be the most efficacious approach. A new approach is required that enables direct delivery to the infant enabling maximum dose to be achieved as early as possible.

AB - Infants born prematurely require higher amounts of dietary docosahexaenoic acid (DHA) than can be supplied through current strategies. Increasing the DHA content of breast milk and formula while achievable may not be the most efficacious approach. A new approach is required that enables direct delivery to the infant enabling maximum dose to be achieved as early as possible.

UR - http://www.scopus.com/record/display.url?eid=2-s2.0-80052801805&origin=inward&txGid=121CF466F6B92D1521932D3748D9C841.ZmAySxCHIBxxTXbnsoe5w%3a149

UR - http://www.scopus.com/inward/record.url?scp=80052801805&partnerID=8YFLogxK

U2 - 10.1002/lite.201100139

DO - 10.1002/lite.201100139

M3 - Article

VL - 23

SP - 200

EP - 202

JO - Lipid Technology

JF - Lipid Technology

SN - 0956-666X

IS - 9

ER -

The DINO trial - challenges for translation into clinical practice

Abstract

Access to Document

Other files and links

Fingerprint

Cite this